Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Best Internet Mastering Stages for Expertise Improvement - 2Watch SpaceX launch 119 payloads to orbit from California early on March 30
- 3Manual for Notorious Fragrances: Immortal Aromas
- 4A mom stopped giving her kids snacks — and sparked a debate about eating habits
- 5Landslides triggered by heavy rainfall kill at least 20 people in Tanzania
- Kenmore East reacts to their best overall delegation award at WNY Model United Nations General Assembly competition
- Step by step instructions to Explore Assessment Ramifications of Disc Rates
- Merz visit highlights new strategic, and strained, Germany-Israel bond
- NASA says Maven spacecraft that was orbiting Mars has gone silent
- 21 Things You Ought to Never Share with Your Childless Companion
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Rescuers attempt to dig free whale stranded on Germany's Baltic coast
- Wait, it's 'Harry Potter and the Philosopher's Stone'? Why the new HBO series name is significant to Americans
- Agricultural drones are taking off globally, saving farmers time and money
